| Submission | Dec. 04, 2024 |
| Submission [Line Items] | |
| Central Index Key | 0001628171 |
| Registrant Name | Revolution Medicines, Inc. |
| Registration File Number | 333-277640 |
| Form Type | S-3 |
| Submission Type | 424B5 |
| Fee Exhibit Type | EX-FILING FEES |
| Offerings | Dec. 04, 2024 USD ($) |
| Offering: 1 | |
| Offering: | |
| Fee Previously Paid | false |
| Rule 457(r) | true |
| Security Type | Equity |
| Security Class Title | Common Stock, $0.0001 par value per share |
| Maximum Aggregate Offering Price | $ 862,500,230 |
| Fee Rate | 0.01531% |
| Amount of Registration Fee | $ 132,049 |
| Offering Note | (1) In accordance with Rules 456(b) and 457(r) under the Securities Act of 1933, as amended, the registrant initially deferred payment of all of the registration fees for the Registration Statement on Form S-3 No. 333-277640), (2) Includes 2,445,652 shares of the registrant’s common stock, $0.0001 par value per share (the “Common Stock”), that the underwriters have an option to purchase and 2,173,917 shares of Common Stock that are issuable upon the exercise of pre-funded |
| Offering: 2 | |
| Offering: | |
| Fee Previously Paid | false |
| Rule 457(r) | true |
| Security Type | Equity |
| Security Class Title | Pre-funded warrants to purchase Common Stock, $0.0001 par value per share |
| Maximum Aggregate Offering Price | $ 0 |
| Fee Rate | 0.01531% |
| Amount of Registration Fee | $ 0 |
| Offering Note | (1) In accordance with Rules 456(b) and 457(r) under the Securities Act of 1933, as amended, the registrant initially deferred payment of all of the registration fees for the Registration Statement on Form S-3 No. 333-277640), (3) Represents the sum of the pre-funded pre-funded pre-funded pre-funded |
| Fees Summary | Dec. 04, 2024 USD ($) |
| Fees Summary [Line Items] | |
| Total Offering | $ 862,500,230 |
| Previously Paid Amount | 0 |
| Total Fee Amount | 132,049 |
| Total Offset Amount | 0 |
| Net Fee | $ 132,049 |
